While an increase in nuclear MIC-1 protein in prostate tumors of African American patients suggests its biological role, high AUC-ROC (serum and urine), sensitivity, and specificity indicate the use of circulatory MIC-1 as a potential biomarker to improve the clinical diagnosis of prostate cancer in African American men. The gene discussed is GDF15; the disease is prostate carcinoma.